Latuda FDA Approved: Sunovion Pharma Schizophrenia Drug

Latuda FDA Approved: Sunovion Pharma Schizophrenia Drug – On Thursday a new drug (Latuda) to treat Schizophrenia in adults from Sunovion Pharma was approved by the United States Food and Drug administration. According to studies, Schizophrenia, which can cause some extreme symptoms ranging from hearing voices to hallucinations, affects up to one per cent of the American population. Reportedly, the drug was approved after four studies which showed that those taking it had less symptoms of schizophrenia than those in the study who were taking a placebo.

Of course, there are some side effects of taking the new drug, as there are with any kind of medication, particularly those which are designed to treat psychiatric problems. The possible side effects which have been listed include high blood sugar, weight gain and diabetes. It is also said to cause death in elderly people when the drug is being used to treat dementia, which the FDA has not approved the medication for.

However, there are a lot of things that suggest that this new drug could be extremely helpful in treating adult patients with Schizophrenia. The psychiatric illness can cause extreme problems for sufferers and it can often make it very difficult to lead a normal life, particularly in social situation when it is not being treated. There are currently millions of people all over the world who are suffering from Schizophrenia but don’t actually realise it because they have yet to seek professional help or treatment through medication.

Leave a Comment